Multiple studies have demonstrated that FGL2 is highly expressed in liver cancer tissues and plays a crucial role in tumor progression by activating specific signaling pathways and modulating immune cell functions [31, 80] (Fig. 8). This evidence concerns the gene FGL2 and neoplasm.